References
INSULIN RESISTANCE
Flow chart of the study population.Sleep parameters assessed by actigraphy during the two weeks. Red line: control group, blue line: light therapy (LT) group.Changes in sleep− and mood−related parameters during the clinical trial. LT, light therapy. (Clock genes’ expression in peripheral blood mononuclear cells before and after the two-week period. Triangles for control group and circles for the light therapy (LT) group. Control, pre: before the clinical trial in the control group; Control, post: after the clinical trial in the control group; LT, pre: before the clinical trial in the light therapy group; LT, post: after the clinical trial in the light therapy group.Baseline characteristics of the study population.Experimental group, LT. Characteristics and changes in the control and experimental groups (LT) at baseline and after the intervention.WBC, white blood cells; TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; HOMA-IR, homeostatic model assessment for insulin resistance; hsCRP, high sensitive C-reactive protein; ACTH, adrenocorticotropic hormone; MHR, mean heart rate; SDNN, standard deviation of normal-to-normal interval; TP, total power; LFnormal, normalized low frequency; HFnormal, normalized high frequency. * 